Michael P Nghiem

Array ( [id] => 4318007 [patent_doc_number] => 06248587 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Method for promoting mesenchymal stem and lineage-specific cell proliferation' [patent_app_type] => 1 [patent_app_number] => 9/198806 [patent_app_country] => US [patent_app_date] => 1998-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 23 [patent_no_of_words] => 14143 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248587.pdf [firstpage_image] =>[orig_patent_app_number] => 198806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560799 [patent_doc_number] => 06361954 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => 'Methods of immunoassay for human CDC6' [patent_app_type] => B1 [patent_app_number] => 09/183266 [patent_app_country] => US [patent_app_date] => 1998-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 26229 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/361/06361954.pdf [firstpage_image] =>[orig_patent_app_number] => 09183266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3980394 [patent_doc_number] => 05958711 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Methods for determining expression of NAG tumor rejection antigen precursor' [patent_app_type] => 1 [patent_app_number] => 9/177909 [patent_app_country] => US [patent_app_date] => 1998-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 9091 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958711.pdf [firstpage_image] =>[orig_patent_app_number] => 177909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4234236 [patent_doc_number] => 06165785 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Bone marrow cultures for developing suppressor and stimulator cells for research and therapeutic applications' [patent_app_type] => 1 [patent_app_number] => 9/178045 [patent_app_country] => US [patent_app_date] => 1998-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14220 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165785.pdf [firstpage_image] =>[orig_patent_app_number] => 178045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4079924 [patent_doc_number] => 06162433 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Non antibiotic selectable markers for live vaccines' [patent_app_type] => 1 [patent_app_number] => 9/175837 [patent_app_country] => US [patent_app_date] => 1998-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5388 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162433.pdf [firstpage_image] =>[orig_patent_app_number] => 175837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404109 [patent_doc_number] => 06232081 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Method for the detection of NF-.kappa.B regulatory factors' [patent_app_type] => 1 [patent_app_number] => 9/172841 [patent_app_country] => US [patent_app_date] => 1998-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 33 [patent_no_of_words] => 39156 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232081.pdf [firstpage_image] =>[orig_patent_app_number] => 172841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4029868 [patent_doc_number] => 05942228 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-24 [patent_title] => 'Human GDP-mannose 4,6 dehydratase' [patent_app_type] => 1 [patent_app_number] => 9/149674 [patent_app_country] => US [patent_app_date] => 1998-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5250 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/942/05942228.pdf [firstpage_image] =>[orig_patent_app_number] => 149674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1309899 [patent_doc_number] => 06610297 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Peptide immunogens for vaccination against and treatment of allergy' [patent_app_type] => B1 [patent_app_number] => 09/125641 [patent_app_country] => US [patent_app_date] => 1998-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11332 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610297.pdf [firstpage_image] =>[orig_patent_app_number] => 09125641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4305028 [patent_doc_number] => 06326354 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Modulation of apoptosis with bid' [patent_app_type] => 1 [patent_app_number] => 9/136879 [patent_app_country] => US [patent_app_date] => 1998-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11078 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326354.pdf [firstpage_image] =>[orig_patent_app_number] => 136879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4257024 [patent_doc_number] => 06258549 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Elisa screening method for inhibitors of human IgE binding to the high affinity receptor, Fc.epsilon.RI.alpha.' [patent_app_type] => 1 [patent_app_number] => 9/101053 [patent_app_country] => US [patent_app_date] => 1998-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 6191 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258549.pdf [firstpage_image] =>[orig_patent_app_number] => 101053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4232707 [patent_doc_number] => 06090388 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Peptide composition for prevention and treatment of HIV infection and immune disorders' [patent_app_type] => 1 [patent_app_number] => 9/100409 [patent_app_country] => US [patent_app_date] => 1998-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25439 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090388.pdf [firstpage_image] =>[orig_patent_app_number] => 100409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4077057 [patent_doc_number] => 05965712 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'LZ-CD23 chimera for inhibition of IgE-mediated allergic disease' [patent_app_type] => 1 [patent_app_number] => 9/100398 [patent_app_country] => US [patent_app_date] => 1998-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 9500 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965712.pdf [firstpage_image] =>[orig_patent_app_number] => 100398 [rel_patent_id] =>[rel_patent_doc_number] =>)